VACCINE UPDATE: A vaccine against the new coronavirus, developed by the U.S. National Institutes of Health and Moderna Inc, has entered the final phase of testing.
Before a vaccine can be approved in the U.S. it must be tested here. Through fall, the COVID-19 Prevention Network will test new vaccines -- each with 30,000 volunteers, theThese tests will determine which vaccine works best and is safest. Vaccines from Johnson & Johnson and Novavax and Pfizer Inc. are all slated for testing.
It usually takes years to develop a new vaccine, but specialists are racing to find an effective vaccine that can curb the"We all feel so helpless right now. There's very little that we can do to combat this virus. And being able to participate in this trial has given me a sense of, that I'm doing something," trial volunteer Jennifer Haller of Seattle told the.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna's COVID-19 vaccine candidate moves into late-stage trialModerna Inc said on Monday it has started a U.S. government-backed late-stage trial for its COVID-19 vaccine candidate, the first to be implemented under the Trump administration's Operation Warp Speed anti-coronavirus program.
Read more »
Inside the China Biotech Firm Racing for a COVID-19 Vaccine‘We Will Share Our Vaccine with the World.’ Inside the Chinese Biotech Firm Leading the Fight Against COVID-19
Read more »
Moderna's Covid-19 vaccine put to final test in biggest trial yetThe experimental drug, developed by the US National Institutes of Health and Moderna, will be tried on 30,000 volunteers in the US who won't know if they're getting the real shot or a placebo in order to see which group experiences more infections.
Read more »
Trump to Promote COVID Vaccine in Election Messaging Pivot: ReportThere’s a major concern with the plan: A vaccine won’t be available until Spring 2021 at the very earliest.
Read more »
Phase 3 clinical trial of investigational vaccine for COVID-19 beginsToday NIH announced the launch of a Phase 3 clinical trial to test candidate vaccine mRNA-1273, developed by NIH, NIAIDNews, and moderna_tx, to prevent COVID19. ACTIV supported the protocol development and Operation WarpSpeed provided funding.
Read more »